HCA Healthcare sees FY18 EPS $8.50-$9.00 including items, consensus $7.52.
Sees FY18 revenue $45B-$46B, consensus $45.32B. Sees FY18 adjusted EBITDA $8.45B-$8.75B. Sees FY18 CapEx approximately $3.5B. 2018 guidance for EPS includes an estimated $50M income tax benefit, or 14c per diluted share, for excess tax benefits related to employee equity award settlements recorded as a component of the provision for income taxes. 2018 guidance assumes the sale of the Company's Oklahoma facilities closing during the first quarter. These facilities had annual revenues of approximately $1B and Adjusted EBITDA of approximately $180M in 2017. 2018 guidance includes an estimated impact of $1.35 EPS related to the Tax Cuts and Jobs Act.